Gavi’s core programming not impacted by US foreign aid freeze
28 FEBRUARY 2025 – Core programming for Gavi, the Vaccine Alliance hasn’t been impacted by the Trump administration’s ongoing gutting of the United States Agency for International Development.
Gavi — a public-private partnership that helps vaccinate more than half the world’s children against infectious diseases — received some $300 million from the U.S. government last December.
Landmark Vaccine Deals Signal Africa’s Shift Toward Local Manufacturing
14 FEBRUARY 2025 – For the first time, an end-to-end mRNA vaccine production platform will be built in Africa, with plans to manufacture 100 million doses annually. A separate cross-continental partnership is advancing homegrown mRNA technology. These landmark agreements, signed in Cairo, are backed by a $1.2 billion investment from Gavi, The Vaccine Alliance. They aim to ensure vaccines are made by Africa, for Africa, and set the stage for expanded local vaccine production and cross-continental collaboration.
Global Partners Invest $45 Million to Boost African Vaccine Production
17 DECEMBER 2024 – In significant efforts to strengthen public health and improve vaccine access in Africa, the U.S. International Development Finance Corporation, the African Development Bank, and the International Finance Corporation (IFC) have jointly announced a $45 million financing package for VaxSen, a subsidiary of Senegal’s Institut Pasteur de Dakar (IPD).
Results from a joint assessment by Africa CDC, CHAI, and PATH
21 SEPTEMBER 2024 – Africa is largely reliant on other regions of the world for lifesaving vaccines. Only one percent of the vaccines administered in Africa are produced locally; the remaining 99 percent are imported. Such an imbalance in production can contribute to unequal access to life-saving vaccines and enormous health disparities between regions.
‘People didn’t believe Africa could be a source of innovation’: how the continent holds the key to future drug research
28 OCTOBER 2024 – Africa has the greatest variety in human genes anywhere on the planet but the world is failing to capitalise on it, according one of the continent’s leading scientists, Prof Kelly Chibale, a man determined to change that. He believes the birthplace of humanity could hold the scientific key to its future.
Mpox crisis: Why do African countries struggle to make or buy vaccines?
12 SEPTEMBER 2024 – After months of delay due to logistics, the first sets of mpox vaccines have finally begun arriving in Democratic Republic of the Congo, donated by Western countries.
The Central African nation is the epicentre of a new mpox outbreak that led the World Health Organization (WHO) to sound its highest alert level last month. In 2024, more than 20,000 mpox cases have been reported and more than 500 people have died. The virus is present in 13 African countries, as well as in some European and Asian nations.
The A-Z on what it would take for Africa to sustainably manufacture vaccines
SEPTEMBER 2024 – To help solve the vast vaccine inequality and vaccine inaccessibility around the world, which is unfolding before our eyes again with mpox, Executive Editor of Business Philippa Larkin interviewed Dr Stavros Nicolaou on what it would take for the continent to be able to manufacture its own vaccines.
Ghana minister of health in SA on mission to hunt for vaccine manufacturing operations
13 AUGUST 2024 – On 12 August, the African Vaccine Manufacturing Initiative (AVMI) hosted Bernard Okoe Boye, the Honourable Minister of Health of Ghana, and his delegation on a fact-finding mission to observe vaccine development and manufacturing operations in Cape Town, South Africa. This significant visit aimed to highlight South Africa’s vaccine production capabilities and discuss potential areas of partnership between Ghana and South Africa to enhance vaccine accessibility and healthcare infrastructure.
Ghana minister of health in SA on mission to hunt for vaccine manufacturing operations
13 AUGUST 2024 – On 12 August, the African Vaccine Manufacturing Initiative (AVMI) hosted Bernard Okoe Boye, the Honourable Minister of Health of Ghana, and his delegation on a fact-finding mission to observe vaccine development and manufacturing operations in Cape Town, South Africa. This significant visit aimed to highlight South Africa’s vaccine production capabilities and discuss potential areas of partnership between Ghana and South Africa to enhance vaccine accessibility and healthcare infrastructure.
Ghana minister of health in SA on mission to hunt for vaccine manufacturing operations
13 AUGUST 2024 – The African Vaccine Manufacturing Initiative (AVMI) hosted Ghana’s Minister of Health, Bernard Okoe Boye, and his group on Monday, August 12, for a fact-finding tour at the vaccine development and production operations in Cape Town, South Africa.
This crucial visit was intended to promote South Africa’s vaccine production capabilities and to identify potential areas of collaboration between Ghana and South Africa to improve vaccine accessibility and healthcare infrastructure.
AU and WHO defend AstraZeneza vaccine in Africa despite doubts in Europe.
18 MARCH 2021 – The African Union (AU) and the World Health Organization (WHO) encouraged on Thursday to continue vaccinating against covid-19 in Africa, even with the AstraZeneca vaccine paralyzed preventively in several European countries by the thrombi that thirty people have suffered.
WHO Director-General calls on G20 to Fight, Unite, and Ignite against COVID-19.
26 MARCH 2020 – Dr Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization, addressed Heads of State at today’s extraordinary G20 Leaders’ Summit focused on COVID-19.